Immuno-Oncology
FDA Approves Durvalumab Plus Standard of Care for SCLC
BY BRIELLE BENYON
Making Cold Breast Cancer Tumors Hot
BY HOPE S. RUGO, MD, FASCO
Immunotherapy in SCLC: Results Are Promising, But Biomarkers Are Needed
BY JESSICA HERGERT
Cytoreducive Nephrectomy in RCC: Challenges Nurses Face
BY ZIAD BAKOUNY, MD, MSC
Immunotherapy Plus Chemo Improves Metastatic TNBC Outcomes
BY GINA COLUMBUS
Advanced NSCLC: Expert Talks Recent Advancements, Shortcomings
BY BRIELLE BENYON
More Immunotherapy May Enter TNBC Space
BY JESSICA HERGERT
Nurse Offers Advice on Discussing AEs With Patients
BY KATHLEEN MADDEN, MSN, RN, APHN, AOCNP, FNP-BC
New Combos Are Coming to the Melanoma Space
BY MARIO SZONL, MD
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.